New Chinese patent is another milestone in our mission to develop smarter, more selective cancer therapies.
🔬 Targeted
✅ Non-toxic to normal cells
🌍 Globally protected IP
Read the news release at bit.ly/4kUYoET
#bioAffinity #Cancer #NewPatent #siRNA #PrecisionMedicine #ChinaPatent #CancerTherapy